213
Views
5
CrossRef citations to date
0
Altmetric
Drug Profile

OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder

, , , &
Pages 1121-1131 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

María Dolores Braquehais, J Antoni Ramos-Quiroga & Leo Sher. (2010) Impulsivity: current and future trends in pharmacological treatment. Expert Review of Neurotherapeutics 10:9, pages 1367-1369.
Read now

Articles from other publishers (4)

Elisa Dalla Vecchia, Niall Mortimer, Viola S. Palladino, Sarah Kittel-Schneider, Klaus-Peter Lesch, Andreas Reif, Annette Schenck & William H.J. Norton. (2019) Cross-species models of attention-deficit/hyperactivity disorder and autism spectrum disorder. Psychiatric Genetics 29:1, pages 1-17.
Crossref
Frances R. Levin, John J. Mariani, Adam Bisaga & Edward V. Nunes. (2015) Ling et al .’s ‘Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder’ . Addiction 110:5, pages 875-876.
Crossref
Kyoung-Sae Na & So-Young Irene Lee. (2012) Effect of Methylphenidate on Learning in Normal Population. Journal of korean Academy of Child and Adolescent Psychiatry 23:2, pages 49-56.
Crossref
Soo-Churl Cho, Bung-Nyun Kim, Tarrant DR Cummins, Jae-Won Kim & Mark A Bellgrove. (2011) Norepinephrine transporter −3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment. Journal of Psychopharmacology 26:3, pages 380-389.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.